Understanding how to improve wound care reimbursement starts with recognizing that a claim can pass a clearinghouse edit, receive payment, and still fail during a payer audit. Missing wound measurements, unsupported debridement depth, incorrect product units, or weak medical-necessity documentation may remain hidden until the payer requests records for months of services.
Resilient MBS recommends improving reimbursement before the audit letter arrives. In 2026, CMS changed Medicare’s payment methodology for many skin-substitute products after Medicare Part B spending on those products rose from $252 million in 2019 to more than $10 billion in 2024. The new payment environment combines tighter margins with increased scrutiny, making preventive claim review essential.
https://resilientmbs.com/medical-billing-services-in-derry/
Resilient MBS views audit readiness as a revenue-cycle control, not a paperwork exercise. Payers may review whether the diagnosis, treatment history, procedure note, product selection, billed units, place of service, and claim data tell the same clinical story.
Resilient MBS also warns against relying on outdated 2026 summaries. CMS withdrew the new skin-substitute LCDs that had been scheduled to take effect on January 1, 2026. Billing teams must therefore verify the currently applicable MAC policy instead of assuming that one withdrawn coverage framework applies nationwide.
An audit-ready workflow should answer five questions:
Resilient MBS recommends answering these questions before claim submission because correcting an individual denial is usually less costly than defending the same documentation weakness across an audit sample.
https://resilientmbs.com/what-is-the-oa-23-denial-code/
Resilient MBS recommends creating a clear timeline from the initial wound assessment through each treatment decision. The record should establish the wound’s cause, location, severity, duration, prior treatment, comorbidities, and response to care.
For advanced treatment, Resilient MBS advises documenting the conservative measures already attempted. Depending on the wound and payer policy, these may include:
Resilient MBS cautions that phrases such as “failed conservative treatment” are rarely strong enough by themselves. The record should identify what was tried, when it was provided, whether the patient followed the plan, and how the wound responded.
Resilient MBS recommends documenting each wound separately with its anatomical location, laterality, length, width, depth, tissue characteristics, drainage, infection status, and surrounding skin condition.
Resilient MBS also recommends using a consistent measurement method across visits. When measurements change sharply without explanation, a payer may question whether the treatment was necessary, whether the billed surface area was accurate, or whether the documentation was copied forward.
https://resilientmbs.com/medical-billing-services-in-omaha/
Resilient MBS emphasizes a rule that prevents many debridement denials: code according to the deepest tissue actually removed, not the deepest tissue visible in the wound.
A wound may expose muscle, but Resilient MBS would not support a muscle-level debridement code when the provider removed only subcutaneous tissue. The procedure note must identify the tissue removed and support the selected code.
Resilient MBS recommends calculating the area actually debrided rather than automatically using the wound’s complete surface area. When multiple wounds are treated to the same depth, their debrided areas may generally be combined for code selection. Wounds treated at different depths must be calculated separately.
| Audit risk | Weak documentation | Audit-ready approach |
|---|---|---|
| Debridement depth | “Wound debrided” | Identify the deepest tissue removed |
| Surface area | Record total wound size only | Record the area actually debrided |
| Multiple wounds | Combine every wound | Combine only when coding rules permit |
| Procedure method | “Wound cleaned” | State the instrument and technique |
| Medical necessity | Repeat the diagnosis | Explain why debridement was required |
| Healing progress | Copy the prior note | Record measurable change or treatment rationale |
Resilient MBS uses this type of comparison during pre-bill audits because small differences between the clinical note and the claim can affect both reimbursement and audit defensibility.
Resilient MBS advises Virginia billing teams to follow the documentation expectations of the applicable Medicare contractor. Palmetto GBA’s debridement checklist calls for the medical decision to perform the procedure, wound characteristics, tissue level removed, treated area, pre- and post-debridement measurements, instrument used, bleeding control, and a signed, complete record.
Resilient MBS recommends updating charge masters and expected-payment tables because CMS finalized payment for many skin-substitute products as incident-to supplies in covered application procedures. CMS established an approximate 2026 payment rate of $127.28 per square centimeter across three FDA regulatory categories in physician-office and hospital-outpatient settings.
Resilient MBS advises practices to compare the current Medicare allowance with product acquisition costs before treatment. Product selection should remain clinically appropriate, but the billing team must understand whether the expected payment covers the product and related operational costs.
Resilient MBS recommends reconciling the product package, HCPCS code, size, quantity applied, quantity discarded, wound area, and claim units before submission.
The audit file should include:
Resilient MBS warns that billing units that exceed the documented wound area or product usage can attract denials, prepayment review, and recoupment requests.
Resilient MBS recommends checking current NCCI and payer edits before separately reporting wound preparation, routine cleansing, debridement, E/M services, or supplies with a skin-substitute application.
CMS contractor guidance states that some wound preparation, cleansing, and related services are included in the application codes. Resilient MBS advises using modifier 25 or another distinct-service modifier only when the record supports a genuinely separate service, not merely to override a claim edit.
Resilient MBS recommends that Texas practices determine whether a planned service is included in the CMS WISeR Model. Beginning in January 2026, selected Original Medicare services in participating states may undergo prior authorization or prepayment medical review. The operational guide includes certain skin-substitute services and has already received code-list updates during 2026.
Resilient MBS advises checking the latest WISeR guide before each applicable service rather than relying on an older saved code list. A code removed from or added to the program can change the required workflow.
Resilient MBS notes that Texas Medicaid updated reimbursement rates for office-setting skin-substitute procedure codes effective June 1, 2026. TMHP also states that authorization, referral, precertification, and claim procedures may differ among managed care organizations.
Resilient MBS recommends separate payer matrices for:
A single “Texas wound care rule” is not sufficient for accurate reimbursement.
Resilient MBS recommends verifying Virginia Medicaid codes by date of service through the DMAS procedure fee files. These files help billing teams confirm reimbursement information, coverage indicators, and authorization flags.
Resilient MBS also notes that, beginning January 1, 2026, Virginia Medicaid’s standard prior-authorization decision timeframe for applicable medical services changed from 14 calendar days to seven calendar days, while expedited decisions remain subject to a 72-hour timeframe.
For denied Virginia Medicaid claims, Resilient MBS recommends distinguishing a corrected claim from a reconsideration or appeal. DMAS billing guidance applies specific resubmission and filing requirements, while managed-care plans maintain their own billing procedures.
Resilient MBS recommends sampling high-risk wound care claims before payers do. The sample should include high-dollar products, repeated applications, multiple wounds, modifier 25 or 59 usage, high debridement units, home-based services, and claims already subject to record requests.
For each sampled claim, Resilient MBS advises completing these steps:
Resilient MBS recommends expanding the audit when the same error appears more than once. A repeated error usually indicates a template, training, charge-master, or workflow problem rather than an isolated staff mistake.
Resilient MBS advises wound care billing leaders to track performance by payer, provider, code, product, and location instead of relying only on total monthly collections.
Useful metrics include:
Resilient MBS uses these metrics to identify where reimbursement is leaking and whether the corrective action reduced the problem in later claims.
Resilient MBS recommends strengthening medical-necessity documentation, coding debridement by the tissue actually removed, calculating units accurately, verifying authorization, reconciling product use, and auditing posted payments.
Resilient MBS commonly reviews risks such as unusually high utilization, repeated product applications, inconsistent wound measurements, excessive units, unsupported modifiers, missing conservative-treatment history, and services that do not show measurable clinical progress.
Resilient MBS recommends documenting the wound location, condition, measurements, medical necessity, tissue removed, debridement depth, treated area, method, instrument, bleeding control, patient tolerance, and treatment plan.
Resilient MBS notes that CMS began paying many skin-substitute products as incident-to supplies and finalized an approximate rate of $127.28 per square centimeter for 2026. Practices must still verify the product, setting, coverage policy, and applicable payer rules.
Resilient MBS advises checking the exact payer and service. Certain Original Medicare services may fall under WISeR, while Texas Medicaid MCO authorization procedures can differ from fee-for-service requirements.
Resilient MBS recommends weekly reviews of denials and authorization failures, monthly coding and payment-variance audits, and an immediate focused audit after a policy change or repeated documentation error.
Resilient MBS helps wound care billing teams connect documentation, coding, product reconciliation, authorization, denial management, and payment review. This approach protects valid reimbursement while reducing the need to rebuild incomplete claims after a payer request.
Billing professionals can learn how Resilient MBS wound care billing services support claim review, reimbursement analysis, denial follow-up, and audit-ready billing workflows.
The best time to improve wound care reimbursement is before the payer selects the claim for review. Resilient MBS recommends starting with a focused sample of high-risk claims, correcting recurring weaknesses, and measuring whether those fixes improve later payment results.